Complement Terminal Pathway Activation and Intrarenal Immune Response in C3 Glomerulopathy

Archive ouverte

Meuleman, Marie-Sophie | Petitprez, Florent | Pickering, Matthew | Le Quintrec, Moglie | Artero, Mikel Rezola | Duval, Anna | Rabant, Marion | Gilmore, Alyssa | Boyer, Olivia | Hogan, Julien | Servais, Aude | Provôt, François | Gnemmi, Vivianne | Eloudzeri, Maeva | Grünenwald, Anne | Buob, David | Boffa, Jean-Jacques | Moktefi, Anissa | Audard, Vincent | Goujon, Jean-Michel | Bridoux, Frank | Thervet, Eric | Karras, Alexandre | Roumenina, Lubka | Frémeaux Bacchi, Véronique | Duong van Huyen, Jean-Paul | Chauvet, Sophie

Edité par CCSD ; American Society of Nephrology -

International audience. Key Points : We evidenced terminal pathway activation (C5b-9 deposits) in most of the glomeruli on kidney biopsy of C3 glomerulopathy. The amount of C5b-9 deposits correlated with disease prognosis in C3 glomerulopathy. Increased terminal pathway activation was found predominantly in a subgroup exhibiting an immuno-fibroblastic signature. Background : C3 glomerulopathy is a rare disease resulting from an overactivation of the complement alternative pathway. Although there is also evidence of terminal pathway activation, its occurrence and consequences on the disease have been poorly studied. Methods : We retrospectively studied a cohort of 42 patients diagnosed with C3 glomerulopathy. We performed centralized extensive characterization of histological parameters. Kidney C5b-9 staining was performed as a marker of terminal pathway activation; intrarenal immune response was characterized through transcriptomic analysis. Results : Eighty-eight percent of biopsies showed C5b-9 deposits in glomeruli. Biopsies were grouped according to the amount of C5b-9 deposits (no or low n =15/42, 36%; intermediate n =15/42, 36%; and high n =12/42, 28%). Patients with high C5b-9 deposits significantly differed from the two other groups of patients and were characterized by a significant higher histological chronicity score ( P = 0.005) and lower outcome-free survival ( P = 0.001). In multivariable analysis, higher glomerular C5b-9 remained associated with poor kidney prognosis after adjustment. One third of the 847 studied immune genes were upregulated in C3 glomerulopathy biopsies compared with controls. Unsupervised clustering on differentially expressed genes identified a group of kidney biopsies enriched in high glomerular C5b-9 with high immune and fibroblastic signature and showed high chronicity scores on histological examination. Conclusions : In a cohort of patients with C3 glomerulopathy, intrarenal terminal pathway activation was associated with specific histological phenotype and disease prognosis.

Consulter en ligne

Suggestions

Du même auteur

Renal Diseases Associated with Hematologic Malignancies and Thymoma in the Absence of Renal Monoclonal Immunoglobulin Deposits

Archive ouverte | Morel, Antoine | CCSD

International audience. In addition to kidney diseases characterized by the precipitation and deposition of overproduced monoclonal immunoglobulin and kidney damage due to chemotherapy agents, a broad spectrum of re...

Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GN

Archive ouverte | Meuleman, Marie Sophie | CCSD

International audience. Background C3 glomerulopathy and idiopathic immunoglobulin-mediated membranoproliferative GN (Ig-MPGN) are rare complement-mediated kidney diseases. Inherited forms of C3 glomerulopathy/Ig-MP...

Ex Vivo Test for Measuring Complement Attack on Endothelial Cells: From Research to Bedside

Archive ouverte | Meuleman, Marie-Sophie | CCSD

International audience. As part of the innate immune system, the complement system plays a key role in defense against pathogens and in host cell homeostasis. This enzymatic cascade is rapidly triggered in the prese...

Chargement des enrichissements...